Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

vedolizumab

vedolizumab
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Entyvio INJECTION, SUBCUTANEOUS 108 mg      
Entyvio POWDER FOR INJECTION, INTRAVENOUS 300 mg      
VIEW MORE GI Drugs, Miscellaneous
Comments:

Entyvio medication guide

ENTYVIO intravenous injection is classified as formulary, restricted to OUTPATIENT/CLINIC use.

ENYTVIO subcutaneous injection is classified as non-formulary. Inpatients should use their home supply.

Reviewed: July 22, 2014 (Entyvio), March 2025 (Entyvio Pen)

 

Vedolizumab subcutaneous injection (Entyvio Pen) Spotlight

Last updated: Apr. 11, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved